BCM Advisors’s Abbott ABT Stock Holding History

BCM Advisors’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-423	Closed	-$16K	–	35
2016 Q4	$16K	Buy	+423	New	+$16.8K	0.01%	69

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCM Advisors's ABT Position: Q1 2017 in Review

BCM Advisors sold out of Abbott (ABT) in Q1 2017, closing a stake of 423 shares — an estimated $16K sold.

BCM Advisors first reported a position in ABT in Q4 2016 and held it in 1 quarter. The position peaked at $16K in Q4 2016. 1,590 funds tracked by Wall St. Rank hold ABT as of Q1 2017.

BCM Advisors reported no remaining Abbott position as of Q1 2017 after selling out during the quarter.
BCM Advisors sold 423 Abbott shares in Q1 2017, an estimated $16K.
BCM Advisors first reported a position in Abbott in Q4 2016 and held it in 1 quarter.
BCM Advisors's Abbott position peaked at $16K in Q4 2016.
1,590 funds tracked by Wall St. Rank held Abbott as of Q1 2017.

Based on BCM Advisors's 13F filing for Q1 2017, filed 12 May 2017.